Aquestive Therapeutics posts Q1 2024 earnings supplemental materials; no financial data provided in filing excerpt

Aquestive Therapeutics, Inc.

2024-Q1 EPS reported -$0.17 revenue$12,053,000

Furnished investor presentation for Q1 2024 earnings results on May 7, 2024.
Presentation available on company website; content not fully reproduced in the filing.
No specific revenue, EPS, or guidance figures visible in the provided excerpt.
Item 7.01 disclosure with Exhibit 99.1; deemed furnished, not filed.
Company trades on Nasdaq under ticker AQST.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.